Theodorou, M., Charalambous, C., Petrou, C., Cylus, J. (2012) Cyprus Health System Review. Health Systems in Transition, 14(6):1–128 Thomsen, E., Er, S., & Fonnesbæk Rasmussen, P. (2008). Denmark 2008 – PPRI Pharma profile. Retrieved October 12, 2013, from the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Information (PPRI) Website: http://whocc.goeg.at/Publications/CountryReports Torgal, J. (2011). Portugal Pharmaceutical Country Profile. Retrieved on May 28th, 2013, from the World Health Organization (WHO) Website: http://www.who.int/medicines/areas/coordination/Portugal_PSCPNarrativeQuestionnaire_27052011.pdf Trade Policy: Countries and regions/Western Balkans. (2013). Retrieved October 10, 2013, from the European Commission Website: http://ec.europa.eu/trade/policy/countries-and-regions/regions/western-balkans/ Tragakes, E. (2003). HiT summary: Albania. Retrieved June 17, 2013, from European Observatory on Health Care Systems Website: http://www.euro.who.int/en/who-we-are/partners/observatory/health-systems-in-transition-hit-series/hit-summaries/albania-hit-summary-2002 Transparancy International Georgia. (2012). The Georgian pharmaceutical market. Retrieved July 10, 2013, from the Transparancy International Georgia Website: http://transparency.ge/en Turcanu, G., Domente, S., Buga, M., & Richardson, E. (2012). Republic of Moldova: health system review. Health Systems in Transition, 14(7), 1–151. Types of diabetes. (2013). Retrieved on October 13th, 2013, from the Diabetes Teaching Center at the University of California San Francisco (DTC-UCSF) Website: http://dtc.ucsf.edu/types-of-diabetes/
U UN Human Rights Council. (2013a). A/HRC/23/42. Retrieved on June 21st, 2013, from the Office of the High Commissioner for Human Rights (OHCHR) Website: http://www.ohchr.org/Documents/HRBodies/HRCouncil/RegularSession/ Session23/A-HRC-23-42_en.pdf UN Human Rights Council. (2013b). A/HRC/23/L.10/Rev.1. Retrieved on June 21st, 2013, from the Office of the High Commissioner for Human Rights (OHCHR) Website: http://ap.ohchr.org/documents/E/HRC/d_res_dec/A_HRC_23_L10_Rev1.doc UN Human Rights Council (2013c) Human Rights Council concludes twenty-third session after adopting 28 texts. UNHRC, press release, New York, 14.06.2013. Retrieved on October 25th, 2013, from the Office of the High Commissioner for Human Rights (OHCHR) Website: http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=13459&LangID=E Usatîi, A. (2011). Republic of Moldova pharmaceutical country profile. Retrieved April 3, 2013, from World Health Organization (WHO) Website: http://www.who.int/medicines/areas/coordination/coordination_assessment/en/index1.html
V Vlădescu, C., Scîntee, G., Olsavszky, V., Allin, S., & Mladovsky, P. (2008). Romania: Health system review. Health Systems in Transition, 10(3), 1-172. Vlahovic, Z., & Radojkovic, D. (2010). Healthcare in Serbia in transition period. EPMA Journal, 2010(1), 601-6. Vogler, S., Habl, C., Bogut, M., & Voncina, L. (2011). Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union member states. Croatian Medical Journal, 52(2), 183-197. Vogler, S., Zimmermann, N., Leopold, C., & de Joncheere, C. (2011). Pharmaceutical policies in European countries in response to the global financial crisis. Southern Med Review, 4(2), 69-79. Voncina, L., Jemiai, N., Merkur, S., Golna, C., Maeda, A., Chao, S., & Dzakula, A. (2006). Croatia: Health system review. Health Systems in Transition, 8(7), 1–108. Vuorenkoski, L., Mladovsky, P., & Mossialos, E. (2008). Finland: Health system review. Health Systems in Transition, 10(4), 1–168.
W/X/Y WHO. (2002). Innovative care for chronic conditions: building blocks for action. Retrieved October 13, 2013, from the World Health Organization (WHO) Website: http://www.who.int/diabetes/publications/icccreport/en/index.html WHO. (2004). Equitable access to essential medicines: a framework for collective action. Retrieved on March 11th, 2013, from the World Health Organization (WHO) Website: http://www.who.int/medicines/publications/policyperspectives/en/
170